Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KVA-12123 by Kineta for Colon Cancer: Likelihood of Approval
KVA-12123 is under clinical development by Kineta and currently in Phase II for Colon Cancer. According to GlobalData, Phase II...
KVA-12123 by Kineta for Pancreatic Cancer: Likelihood of Approval
KVA-12123 is under clinical development by Kineta and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase II...
KVA-12123 by Kineta for Bladder Cancer: Likelihood of Approval
KVA-12123 is under clinical development by Kineta and currently in Phase II for Bladder Cancer. According to GlobalData, Phase II...
KVA-12123 by Kineta for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
KVA-12123 is under clinical development by Kineta and currently in Phase II for Transitional Cell Cancer (Urothelial Cell Cancer). According...
KVA-12123 by Kineta for Leiomyosarcoma: Likelihood of Approval
KVA-12123 is under clinical development by Kineta and currently in Phase II for Leiomyosarcoma. According to GlobalData, Phase II drugs...